Cooley Shortlisted Across Multiple Categories in LMG Life Sciences Americas Awards
New York – July 21, 2026 – Cooley was shortlisted across 11 categories for the 2026 LMG Life Sciences Americas Awards, which recognize the most distinguished lawyers and firms across the US, Canada and Brazil for exemplary work in life sciences.
The firm was shortlisted in the following practice area award categories: Corporate Firm of the Year, Licensing and Collaboration Firm of the Year, M&A Firm of the Year, and Venture Capital Firm of the Year.
Seven Cooley lawyers were also shortlisted for individual awards:
- Jamie Leigh – M&A Attorney of the Year
- Christian Plaza – Corporate Attorney of the Year
- Ryan Sansom – VC Attorney of the Year
- Sonia Nath – Regulatory Attorney of the Year – FDA Pharmaceutical
- Eric Greig – Regulatory Attorney of the Year – Pricing and Reimbursement
- Chad Shear – General Patent Litigator of the Year – California
- Betsy Flanagan – General Patent Litigator of the Year – Midwest
An awards ceremony will be held in New York City on September 10.
Life sciences breakthroughs happen with Cooley. The firm’s collaborative approach draws upon unparalleled life sciences sector experience to drive strategic solutions and resolve challenges.
The firm’s practitioners are versed in all aspects of life sciences technologies, delivering an unmatched combination of innovative legal guidance, deep industry knowledge and practical understanding of clients’ needs. Many Cooley lawyers worked as pharmaceutical marketing professionals, business consultants, financial leaders, biotech researchers and in-house counsel at life sciences companies before joining the firm. Cooley serves as trusted counsel to 2,500+ public and private life sciences company clients worldwide, including nearly 50% of the Nasdaq Biotechnology Index. The firm’s clients include innovative biotech and specialty pharmaceutical companies at the forefront of new technologies, including cell and gene therapies, artificial intelligence-led drug discovery, and new vaccine technologies.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.
Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.
Related Contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.